Kroger sales growth (excl. fuel) in Q3
Short Answer
Kroger is not expected to see identical sales growth (excl. fuel) in Q3 2026. The company significantly lowered its full-year identical sales growth guidance for fiscal year 2026 due to macroeconomic uncertainty and specific headwinds; the market prices this outcome at 0.0%.
1. Market Behavior & Drivers
This market has shown no price movement, holding steady at a 1.0% probability. Trading volume has been zero since the market's inception.
The lack of activity reflects the absence of new, market-moving information. Kroger has not yet released its Q3 2026 financial results. The most recent corporate filing is for Q2 2026, which was reported on September 11, 2026. Without the relevant earnings data to price, traders have not entered the market.
- Low Q3 2026 identical sales growth is likely, per revised full-year guidance.
- Macroeconomic uncertainty and headwinds appear to constrain Q3 sales growth.
- High-cost GLP-1 drugs are expected to negatively impact Kroger's pharmacy sales.
Who Wins and Why
| Outcome | Market | Model | Why |
|---|---|---|---|
| Above -0.5% | 0.0% | 0.0% | Research does not highlight strong supporting evidence. |
| Above -1% | 0.0% | 0.0% | Research does not highlight strong supporting evidence. |
| Above -2% | 0.0% | 0.0% | Research does not highlight strong supporting evidence. |
| Above 0.5% | 0.0% | 0.0% | Model and market aligned |
| Above 0% | 0.0% | 0.0% | Research does not highlight strong supporting evidence. |
Current Context
Kroger's Q3 2026 financial results are not yet available. As of September 12, 2026, Kroger had not reported its Q3 2026 financial results [^][^][^][^]. The company reported its Q2 2026 results on September 11, 2026 [^][^][^]. For fiscal year 2026, Kroger updated its identical sales (excluding fuel) guidance to a range of 0.2% to 0.8% [^][^][^]. Separately, the company provided full-year identical sales growth (excluding fuel) guidance of 1.0% to 2.0% for fiscal year 2026 [^].
Management expects Q3 identical sales growth to surpass Q4. During the Q2 2026 earnings call, management anticipated Q3 identical sales growth (excluding fuel) would be slightly better than Q4 [^]. Kroger's Q3 outlook includes sales headwinds from lingering Cyclospora impacts [^]. It also projects an approximately 150 basis point impact from new high-cost drugs, including GLP-1s, which were added to the formulary in January [^].
2. Price Chart
Historical Price (Probability)
Outcome probability
Date
3. Market Data
Contract Snapshot
This market resolves based on Kroger's official identical sales growth (excluding fuel) in Q3. For a contract such as "Above -2%", a "Yes" resolution triggers if growth is greater than -2%, and a "No" resolution triggers if it is -2% or less. Trading for this market concludes on December 3, 8:00 AM EST, with a maximum payout date set for April 2, 2027.
Available Contracts
Market options and current pricing
| Outcome bucket | Yes (price) | No (price) | Last trade probability |
|---|---|---|---|
| Above -0.5% | $0.99 | $0.99 | 0% |
| Above -1% | $0.99 | $0.99 | 0% |
| Above -2% | $0.99 | $0.99 | 0% |
| Above 0.5% | $0.99 | $0.99 | 0% |
| Above 0% | $0.99 | $0.99 | 0% |
| Above 1.5% | $0.99 | $0.99 | 0% |
| Above 1% | $0.99 | $0.99 | 0% |
| Above 2% | $0.99 | $0.99 | 0% |
| Above 3% | $0.99 | $0.99 | 0% |
Market Discussion
As of September 12, 2026, Kroger has not yet reported its fiscal Q3 2026 sales growth excluding fuel, with Q3 typically ending in early November and results generally reported in early December [^][^][^][^]. Despite this, public discussion references Q3 fiscal 2026 identical sales growth excluding fuel of 2.6%, driven by strength in pharmacy and e-commerce, within the context of Kroger's narrowed full-year guidance of 2.8%–3.0% [^][^][^]. Broader market sentiment concerning Kroger is mixed as of mid-September 2026, with some social media indicators showing a neutral-to-bearish outlook while others note bullish activity, and analyst ratings remain divided [^][^][^][^].
4. Trust Index
5. How will the growing adoption of GLP-1 drugs and other high-cost medications impact Kroger's pharmacy sales in Q3 2026?
| IRA headwind to identical sales (excl. fuel) for full year 2026 | 140 basis points [^][^][^][^] |
|---|---|
| Projected IRA headwind in Q4 2026 | approximately 150 basis points [^][^][^][^] |
| Kroger revised full-year 2026 identical sales guidance (excl. fuel) | 0.2% to 0.8% [^] |
High-cost medications will negatively affect Kroger's Q3 2026 pharmacy sales. The increasing adoption of GLP-1 drugs and other high-cost medications is anticipated to negatively affect Kroger's pharmacy sales in Q3 2026, primarily due to the Inflation Reduction Act (IRA) [^][^][^][^]. While GLP-1 medications are contributing to growth in core pharmacy script volume, their positive impact on sales is being counteracted by IRA-mandated pricing and reimbursement changes, alongside a broader market shift from brand-name to generic prescriptions [^][^][^].
The Inflation Reduction Act will create significant sales headwinds for Kroger. The IRA is projected to impose a 140 basis point headwind on identical sales (excluding fuel) for Kroger for the entirety of 2026 [^][^][^][^]. This headwind is expected to intensify to approximately 150 basis points in Q4 2026, as more high-cost drugs, including GLP-1s, are integrated into the formulary in January [^][^][^][^]. Consequently, Kroger has revised its full-year 2026 identical sales guidance (excluding fuel) downward, citing these pharmacy-related headwinds among other factors [^].
6. What is the Wall Street analyst consensus for Kroger's Q3 2026 identical sales growth (excluding fuel)?
| Q2 2026 Identical Sales Growth (excluding fuel) | 0.2% (ended August 15, 2026) [^][^][^][^] |
|---|---|
| Full-Year 2026 Identical Sales Growth Guidance (updated, excluding fuel) | 0.2% to 0.8% [^][^][^][^][^][^][^] |
| Full-Year 2026 Identical Sales Growth Guidance (previous, excluding fuel) | 1.0% to 2.0% [^][^][^][^][^][^][^] |
Analyst consensus for Kroger's Q3 2026 identical sales is not available. The provided research does not contain information regarding Wall Street analyst consensus for Kroger's Q3 2026 identical sales growth (excluding fuel). However, Kroger's recent performance indicated the company reported identical sales growth (excluding fuel) of 0.2% for the second quarter of 2026, which concluded on August 15, 2026 [^][^][^][^].
Kroger revised its full-year identical sales guidance downwards after Q2 results. Following these Q2 2026 results, Kroger revised its full-year 2026 identical sales growth guidance (excluding fuel) downwards to a range of 0.2% to 0.8% [^][^][^][^][^][^][^]. This marked a reduction from the prior guidance of 1.0% to 2.0% [^][^][^][^][^][^][^]. During its Q2 2026 earnings call, Kroger management stated that they expect identical sales without fuel to be marginally better in Q3 2026 compared to Q4 2026 [^]. Management also anticipates increased sales headwinds in Q4 2026, citing the accelerated impact of the Inflation Reduction Act, estimated at approximately 150 basis points, and challenging comparisons to prior year benefits from weather-related sales and third-party delivery partnerships [^].
7. How does Kroger's updated FY2026 sales guidance compare to recent forecasts from competitors like Albertsons and Walmart?
| Kroger FY2026 Identical Sales Guidance | 0.2%-0.8% (September 11, 2026) [^][^][^] |
|---|---|
| Albertsons FY2026 Identical Sales Expectation | (1.5)% to (0.5)% (July 2026) [^][^] |
| Walmart FY2027 Sales Guidance | 3.5% to 4.5% growth (constant currency) [^][^][^] |
Kroger significantly lowered its full-year 2026 sales guidance due to various pressures. On September 11, 2026, Kroger revised its identical sales guidance (excluding fuel) for the full fiscal year 2026 downwards to a range of 0.2%–0.8%. This marks a substantial reduction from its previous expectation of 1.0%–2.0% [^][^][^]. The company attributed this adjustment to several factors, including a significant 140 basis point headwind stemming from the Inflation Reduction Act, alongside other challenges such as generic prescription trends, egg deflation, and issues related to Cyclospora [^][^][^].
Albertsons also cut its sales forecast, contrasting with Walmart's robust projections. Similarly impacted, Albertsons revised its fiscal 2026 identical sales expectation in July 2026 to a range of (1.5)% to (0.5)%, a reduction from its initial forecast of 0.0% to 1.0% [^][^]. Albertsons specifically cited an estimated 150 basis point headwind attributed to the Inflation Reduction Act as a key reason for its revised outlook [^]. In stark contrast to these downward revisions, Walmart issued optimistic full-year sales guidance for FY2027, projecting 3.5% to 4.5% growth (constant currency) [^][^][^]. Walmart's positive outlook reflects its continued ability to gain market share and effectively mitigate specific industry headwinds, setting its forecast apart from its competitors [^][^][^].
8. What do alternative data sources, such as credit card transaction data, indicate about consumer spending trends at Kroger during Q3 2026?
| Full-Year 2026 Identical Sales Guidance (Excluding Fuel) | 0.2% to 0.8% (as of September 11, 2026) [^][^][^] |
|---|---|
| Q2 2026 Identical Sales Growth (Excluding Fuel) | 0.2% [^] |
| Estimated CPG Spending Shift | $12 billion (away from Kroger) [^][^][^] |
Kroger adjusted full-year sales guidance due to challenging market conditions. The company lowered its full-year 2026 guidance for identical sales, excluding fuel, to a range of 0.2% to 0.8% as of September 11, 2026. This downward revision was primarily attributed to macroeconomic uncertainty and difficult consumer spending trends observed during Q3 2026 [^][^][^].
Alternative data revealed heightened consumer price sensitivity and spending shifts. Findings from mid-2026 indicated a significant increase in price sensitivity among consumers, particularly within lower-income households, which led to reduced shopping trips and overall spending [^]. This behavioral shift resulted in an estimated $12 billion in CPG spending moving away from Kroger towards competing retailers such as Walmart, Amazon, and Costco [^][^][^]. While Kroger successfully maintained overall traffic in Q2 2026, showing a 0.5% year-over-year increase, its identical sales growth, excluding fuel, slowed to 0.2% in the same quarter as consumers increasingly prioritized value and essential purchases [^][^].
9. Which macroeconomic indicators, particularly the Consumer Price Index for food at home, signaled shifts in grocery spending during Q3 2026?
| CPI Food-at-Home MoM (July 2026) | unchanged [^][^] |
|---|---|
| CPI Food-at-Home YoY (July 2026) | increased 2.7% [^][^] |
| Kroger Full-Year 2026 Identical Sales Guidance (updated) | 0.2% to 0.8% [^][^] |
Grocery spending shifts were signaled by July 2026 CPI data. The Consumer Price Index (CPI) for food at home for July 2026 indicated shifts in grocery spending during Q3 2026. While the CPI for food-at-home remained unchanged month-over-month, it increased by 2.7% over the 12 months ending in July 2026 [^][^].
Macroeconomic pressures caused Kroger to revise its 2026 sales forecast. Kroger updated its full-year 2026 guidance for identical sales growth (excluding fuel) due to these macroeconomic pressures, lowering the anticipated range from 1-2% to 0.2-0.8% [^][^]. This revised outlook followed identical sales growth (excluding fuel) of 0.2% for the second quarter of 2026 [^][^][^]. Kroger's management anticipates that Q3 2026 identical sales growth will be marginally better than the expected performance for Q4 2026 [^].
10. What Could Change the Odds
Key Catalysts
Kroger's Q2 2026 identical sales growth (excluding fuel) registered 0.2%, leading to a revised full-year 2026 identical sales (excl. fuel) guidance of 0.2% to 0.8%, down from the previous 1% to 2% [^][^][^][^]. Management projects slightly better identical sales (excluding fuel) in Q3 2026 versus Q4 2026, as Q4 faces approximately 150 basis points from Inflation Reduction Act (IRA) headwinds, alongside tougher year-over-year comparisons from third-party delivery partnerships and weather benefits [^][^][^]. The fiscal 2026 full-year outlook includes an approximately 130 basis point headwind attributed to the IRA [^]. Kroger's Q3 2026 earnings are anticipated on or around November 26, 2026 [^]. The company has not provided a specific quarterly identical sales growth forecast for Q3 2026 [^].
Bullish catalysts for Kroger include cost savings, pharmacy margin contributions, e-commerce profitability improvements, and ongoing share repurchases [^] [^] [^] . Bearish catalysts encompass persistent macroeconomic uncertainty, cautious consumer spending, IRA pharmacy impacts, lingering Cyclospora effects, and difficult year-over-year comparisons [^][^][^].
Key Dates & Catalysts
- Expiration: April 02, 2027
- Closes: April 02, 2027
11. Decision-Flipping Events
- Trigger: Kroger's Q2 2026 identical sales growth (excluding fuel) registered 0.2%, leading to a revised full-year 2026 identical sales (excl.
- Trigger: Fuel) guidance of 0.2% to 0.8%, down from the previous 1% to 2% [^] [^] [^] [^] .
- Trigger: Management projects slightly better identical sales (excluding fuel) in Q3 2026 versus Q4 2026, as Q4 faces approximately 150 basis points from Inflation Reduction Act (IRA) headwinds, alongside tougher year-over-year comparisons from third-party delivery partnerships and weather benefits [^] [^] [^] .
- Trigger: The fiscal 2026 full-year outlook includes an approximately 130 basis point headwind attributed to the IRA [^] .
13. Historical Resolutions
Historical Resolutions: 7 markets in this series
Outcomes: 1 resolved YES, 6 resolved NO
Recent resolutions:
- KXKR-26SEPIDSALES-3.0: NO (Sep 11, 2026)
- KXKR-26SEPIDSALES-2.5: NO (Sep 11, 2026)
- KXKR-26SEPIDSALES-2.0: NO (Sep 11, 2026)
- KXKR-26SEPIDSALES-1.5: NO (Sep 11, 2026)
- KXKR-26SEPIDSALES-1.0: NO (Sep 11, 2026)
